A collaboration which is progressing cancer drug discovery is building on research from Newcastle University. Astex ...
A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...
AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...
The setback dims the outlook for a medicine Pfizer sees as an important contributor going forward, though some analysts are ...
A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.
Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. In a rare move, nonprofit organization ...
Recent approvals for Corcept Therapeutics and Merck have injected momentum into the space, where GSK, Allarity Therapeutics, ...
SurvivorNet on MSN
‘A watershed moment’: Revolution Medicines chief development officer Dr. Alan Sandler on the breakthrough giving new hope in pancreatic cancer
Revolution Medicines has spent nearly a decade chasing what Dr. Alan Sandler, the Chief Development Officer at the company, ...
Researchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from breaking when cells copy damaged genetic material, a discovery that could ...
The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Ascentage Pharma Group Internat ...
Low-dose drug combinations may mean treatment for cancer patients is measured by how well a person lives as much as how long ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results